Ligand-independent activation of the arylhydrocarbon receptor by ETK (Bmx) tyrosine kinase helps MCF10AT1 breast cancer cells to survive in an apoptosis-inducing environment

Biological Chemistry

Volumn 392, Issue 10, 2011, Pages 897-908

  Fujisawa, Yasuko ^a   Li, Wen ^a   Wu, Dalei ^a   Wong, Patrick ^a   Vogel, Christoph ^a   Dong, Bin ^a   Kung, Hsing Jien ^b   Matsumura, Fumio ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

arylhydrocarbon receptor; breast cancer; endothelial tyrosine kinase; ligand independent activation

Indexed keywords

3,5 DI TERT BUTYL ALPHA CYANO 4 HYDROXYTHIOCINNAMAMIDE; ANTISENSE OLIGONUCLEOTIDE; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; DOXORUBICIN; ENDOTHELIAL TYROSINE KINASE; ESTROGEN RECEPTOR; OMEPRAZOLE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; ENZYME ACTIVATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; STARVATION; UPREGULATION; WILD TYPE;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; CYTOCHROME P-450 CYP1A1; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROTEIN-TYROSINE KINASES; RECEPTORS, ARYL HYDROCARBON; TRANSFECTION;

EID: 80052722954     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2011.087     Document Type: Article

References (48)

1. Angus, W.G., Larsen, M.C., and Jefcoate, C.R. (1999). Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status. Carcinogenesis 20, 947-955
2. Backlund, M., Johansson, I., Mkrtchian, S., and Ingelman-Sundberg, M. (1997). Signal transduction-mediated activation of the aryl hydrocarbon receptor in rat hepatoma H4IIE cells. J. Biol. Chem. 272, 31755-31763
3. Backlund, M. and Ingelman-Sundberg, M. (2005). Regulation of aryl hydrocarbon receptor signal transduction b y protein tyrosine kinases. Cell. Signal. 17, 39-48
4. Bock, K.W. and Kohle, C. (2010). Contributions of the Ah receptor to bilirubin homeostasis and its antioxidative and atheroprotective functions. Biol. Chem. 391, 645-653
5. Chen, R., Kim, O., Li, M., Xiong, X., Guan, J.L., Kung, H.J., Chen, H., Shimizu, Y., and Qiu, Y. (2001). Regulation of the PHdomain- containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain. Nat. Cell Biol. 3, 439-444
6. Chen, K.Y., Huang, L.M., Kung, H.J., Ann, D.K., and Shih, H.M. (2004). The role of tyrosine kinase Etk/Bmx in EGF-induced apoptosis of MDA-Mβ468 breast cancer cells. Oncogene 23, 1854-1862
7. Chopra, M. and Schrenk, D. (2011). Dioxin toxicity, aryl hydrocarbon receptor signaling, and apoptosis-persistent pollutants affect programmed cell death. Crit. Rev. Toxicol. 41, 292-320
8. Currier, N., Solomon, S.E., Demicco, E.G., Chang, D.L., Farago, M., Ying, H., Dominguez, I., Sonenshein, G.E., Cardiff, R.D., Xiao, Z.X., et al. (2005). Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Toxicol. Pathol. 33, 726-737
9. Daujat, M., Charrasse, S., Faßre, I., Lesca, P., Jounaidi, Y., Larroque, C., Poellinger, L., and Maurel, P. (1996). Induction of CYP1A1 gene by benzimidazole derivatives during Caco-2 cell differentiation. Evidence for an aryl-hydrocarbon receptor-mediated mechanism. Eur. J. Biochem. 237, 642-652
10. Der, G. (2003). An overview of proton pump inhibitors. Gastroenterol. Nurs. 26, 182-190
11. Dewa, Y., Nishimura, J., Jin, M., Kawai, M., Saegusa, Y., Kenmochi, S., Shimamoto, K., Harada, T., Shibutani, M., and Mitsumori, K. (2011). Immunohistochemical analyses at the late stage of tumor promotion by oxfendazole in a rat hepatocarcinogenesis model. Arch. Toxicol. 85, 155-162
12. Du, J., Yang, S., Wang, Z., Zhai, C., Yuan, W., Lei, R., Zhang, J., and Zhu, T. (2008). Bone morphogenetic protein 6 inhibit stressinduced breast cancer cells apoptosis via both smad and p38 pathways. J. Cell. Biochem. 103, 1584-1597
13. Dzeletovic, N., Mcguire, J., Daujat, M., Tholander, J., Ema, M., Fujii-Kuriyama, Y., Bergman, J., Maurel, P., and Poellinger, L. (1997). Regulation of dioxin receptor function by omeprazole. J. Biol. Chem. 272, 12705-12713
14. Esser, C., Rannug, A., and Stockinger, B. (2009). The aryl hydrocarbon receptor in immunity. Trends Immunol. 30, 447-454
15. Gradin, K., Mcguire, J., Wenger, R.H., Kvietikova, I., Fhitelaw, M.L., Toftgard, R., Tora, L., Gassmann, M., and Poellinger, L. (1996). Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol. Cell. Biol. 16, 5221-5231
16. Hankinson, O., Andersen, R.D., Birren, B.W., Sander, F., Negishi, M., and Nebert, D.W. (1985). Mutations affecting the regulation of transcription of the cytochrome P1-450 gene in the mouse Hepa-1 cell line. J. Biol. Chem. 260, 1790-1795
17. Hatakeyama, M., Zou, E., and Matsumura, F. (2002). Comparison of the characteristic of estrogenic action patterns of beta-HCH and heregulin beta1 in MCF-7 human breast cancer cells. J. Biochem. Mol. Toxicol. 16, 209-219
18. He, H., Hirokawa, Y., Gazit, A., Yamashita, Y., Mano, H., Kawakami, Y., Kawakami, Hsieh, C.Y., Kung, H.J., Lessene, G., et al. (2004). The Tyr-kinase inhibitor AG879, that blocks the ETKPAK1 interaction, suppresses the RAS-induced PAK1 activation and malignant transformation. wsee commentx. Cancer Biol. Ther. 3, 96-101
19. Huang, B. and Porter, G. (2005). Expression of proline-rich Aktsubstrate PRAS40 in cell survival pathway and carcinogenesis. Acta Pharmacol. Sin. 26, 1253-1258
20. Kikuchi, H. (2002). [Regulation of cytochrome P-450 (CYP) genes by nuclear receptors]. Nippon Eiseigaku Zasshi 56, 622-628
21. Kikuchi, H. and Hossain, A. (1999). Signal transduction-mediated CYP1A1 induction by omeprazole in human HepG2 cells. Exp.Toxicol. Pathol. 51, 342-346
22. Kikuchi, H., Kato, H., Mizuno, M., Hossain, A., Ikawa, S., Miyazaki, J., and Watanaße, M. (1996). Differences in inducibility of CYP1A1-mRNA by benzimidazole compounds between human and mouse cells: evidences of a human-specific signal transduction pathway for CYP1A1 induction. Arch. Biochem. Biophys. 334, 235-240
23. Kikuchi, H., Hossain, A., Yoshida, H., and Kobayashi, S. (1998). Induction of cytochrome P-450 1A1 by omeprazole in human HepG2 cells is protein tyrosine kinase-dependent and is not inhibited by alpha-naphthoflavone. Arch. Biochem. Biophys. 358, 351-358
24. Lemaire, G., Delescluse, C., Pralavorio, M., Ledirac, N., Lesca, P., and Rahmani, R. (2004). The role of protein tyrosine kinases in CYP1A1 induction by omeprazole and thiAβendazole in rat hepatocytes. Life Sci. 74, 2265-2278
25. Lesca, P., Peryt, B., Larrieu, G., Alvinerie, M., Galtier, P., Daujat,M., Maurel, P., and Hoogenboom, L. (1995). Evidence for the ligand-independent activation of the AH receptor. Biochem. Biophys. Res. Commun. 209, 474-482
26. Liu, J.W., Chandra, D., Rudd, M.D., Butler, A.P., Pallotta, V., Brown, D., Coffer, P.J., and Tang, D.G. (2005). Induction of prosurvival molecules by apoptotic stimuli: involvement of FOXO3a and ROS. Oncogene 24, 2020-2031
27. Ma, C., Marlowe, J.L., and Puga, A. (2009). The aryl hydrocarbon receptor at the crossroads of multiple signaling pathways. EXS. 99, 231-257
28. Matsumura, F., Puga, A., and Tohyama, C. (2009). Biological functions of the arylhydrocarbon receptor: beyond induction of cytochrome P450s. Introduction to this special issue. Biochem. Pharmacol. 77, 473
29. Mazina, O., Park, S., Sano, H., Wong, P., and Matsumura, F. (2004). Studies on the mechanism of rapid activation of protein tyrosine phosphorylation activities, particularly c-Src kinase, by TCDD in MCF10A. J. Biochem. Mol. Toxicol. 18, 313-321
30. Mimura, J., Yamashita, K., Nakamura, K., Morita, M., Takagi, T.N., Nakao, K., Ema, M., Sogawa, K., Yasuda, M., Katsuki, M.,et al. (1997). Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells 2, 645-654
31. Nguyen, L.P. and Bradfield, C.A. (2008). The search for endogenous activators of the aryl hydrocarbon receptor. Chem. Res. Toxicol.21, 102-116
32. Pandey, S. and Wang, E. (1995). Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse. J. Cell. Biochem. 58, 135-150
33. Park, S. and Matsumura, F. (2006). Characterization of anti-apoptotic action of TCDD as a defensive cellular stress response reaction against the cell damaging action of ultra-violet irradiation in an immortalized normal human mammary epithelial cell line, MCF10A. Toxicology 217, 139-146
34. Park, S., Mazina, O., Kitagawa, A., Wong, P., and Matsumura, F. (2004). TCDD causes suppression of growth and differentiation of MCF10A, human mammary epithelial cells by interfering with their insulin receptor signaling through c-Src kinase and ERK activation. J. Biochem. Mol. Toxicol. 18, 322-331
35. Przybytkowski, E., Joly, E., Nolan, C.J., Hardy, S., Francoeur, A.M., Langelier, Y., and Prentki, M. (2007). Upregulation of cellular triacylglycerol - free fatty acid cycling by oleate is associated with long-term serum-free survival of human breast cancer cells. Biochem. Cell. Biol. 85, 301-310
36. Qiu, Y., Robinson, D., Pretlow, T.G., and Kung, H.J. (1998). Etk/ Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 39-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells. Proc. Natl. Acad. Sci. USA 95, 3644-3649
37. Raychaudhuri, B., Nebert, D.W., and Puga, A. (1990). The murine Cyp1a-1 gene negatively regulates its own transcription and that of other members of the aromatic hydrocarbon-responsive wAhx gene battery. Mol. Endocrinol. 4, 1773-1781
38. Robinson, D., He, F., Pretlow, T., and Kung, H.J. (1996). A tyrosine kinase profile of prostate carcinoma. Proc. Natl. Acad. Sci. USA 93, 5958-5962
39. Roblin, S., Okey, A.B., and Harper, P.A. (2004). AH receptor antagonist inhibits constitutive CYP1A1 and CYP1B1 expression in rat BP8 cells. Biochem. Biophys. Res. Commun. 317, 142-148
40. Shiizaki, K., Ohsako, S., Koyama, T., Nagata, R., Yonemoto, J., and Tohyama, C. (2005). Lack of CYP1A1 expression is involved in unresponsiveness of the human hepatoma cell line SK-HEP-1 to dioxin. Toxicol. Lett. 160, 22-33
41. Shin, S.R., Sanchez-Velar, N., Sherr, D.H., and Sonenshein, G.E. (2006). 7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kB. Cancer Res. 66, 2570-2575
42. Skladanowski, A. and Konopa, J. (1993). Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumour cells. Biochem. Pharmacol. 46, 375-382
43. Thomsen, J.S., Wang, X., Hines, R.N., and Safe, S. (1994). Restoration of aryl hydrocarbon (Ah) responsiveness in MDA-Mβ 231 human breast cancer cells by transient expression of the estrogen receptor. Carcinogenesis 15, 933-937
44. Trombino, A.F., Near, R.I., Matulka, R.A., Yang, S., Hafer, L.J., Toselli, P.A., Kim, D.W., Rogers, A.E., Sonenshein, G.E., and Sherr, D.H. (2000). Expression of the aryl hydrocarbon receptor/ transcription factor (AhR) and AhR-regulated CYP1 gene transcripts in a rat model of mammary tumorigenesis. Breast Cancer Res. Treat. 63, 117-131
45. Weiss, C., Kolluri, S.K., Kiefer, F., and Gottlicher, M. (1996). Complementation of Ah receptor deficiency in hepatoma cells: negative feedback regulation and cell cycle control by the Ah receptor. Exp. Cell Res. 226, 154-163
46. Wong, P.S. and Matsumura, F. (2007). Promotion of breast cancer by βhexachlorocyclohexane in MCF10AT1 cells and MMTVneu mice. BMC Cancer 7, 130
47. Wong, P.S., Li, W., Vogel, C.F., and Matsumura, F. (2009). Characterization of MCF mammary epithelial cells overexpressing the arylhydrocarbon receptor (AhR). BMC Cancer 9, 234
48. Zou, E. and Matsumura, F. (2003). Long-term exposure to βhexachlorocyclohexane (βHCH) promotes transformation and invasiveness of MCF-7 human breast cancer cells. Biochem. Pharmacol. 66, 831-840